ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

DCPH Deciphera Pharmaceuticals Inc

14,67
0,09 (0,62%)
23 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Deciphera Pharmaceuticals Inc DCPH NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,09 0,62% 14,67 22:08:30
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,57 14,56 15,20 14,67 14,58
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.4.202413:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
27.2.202413:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
20.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202422:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07.2.202413:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.2.202413:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06.2.202413:10EDGAR2Form 8-K - Current report
06.2.202413:00BWDeciphera Pharmaceuticals Announces Fourth Quarter and Full..
01.2.202422:50BWDeciphera Pharmaceuticals to Announce Fourth Quarter and..
01.2.202413:00BWDeciphera Pharmaceuticals to Present at the Guggenheim..
18.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202417:13BWDeciphera Pharmaceuticals Presents Long-Term Follow-Up..
08.1.202413:14EDGAR2Form 8-K - Current report
08.1.202413:00BWDeciphera Pharmaceuticals Announces Planned 2024 Corporate..
05.1.202413:00BWDeciphera Pharmaceuticals Announces Nature Medicine..
02.1.202413:00BWDeciphera Pharmaceuticals to Present at the 42nd Annual J.P...
14.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202300:05EDGAR2Form 144 - Report of proposed sale of securities
29.11.202313:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..
07.11.202313:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
31.10.202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202312:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30.10.202312:06EDGAR2Form 8-K - Current report
30.10.202312:01BWDeciphera Pharmaceuticals Announces Third Quarter 2023..
30.10.202312:00BWDeciphera Pharmaceuticals Announces Positive Top-line..
29.9.202315:00PRNUSMedison Pharma Announces Public Formulary Listing of..
19.9.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.9.202323:00BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
05.9.202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
18.8.202322:05BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
09.8.202313:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202313:06EDGAR2Form 8-K - Current report
09.8.202313:00BWDeciphera Pharmaceuticals Announces Second Quarter 2023..
03.8.202322:20EDGAR2Form 8-K - Current report
03.8.202322:15BWDeciphera Pharmaceuticals Announces Retirement of Daniel L...
02.8.202313:00BWDeciphera Pharmaceuticals to Announce Second Quarter 2023..
25.5.202323:00BWDeciphera Pharmaceuticals to Present Data from INTRIGUE..
23.5.202313:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
08.5.202313:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..
03.5.202313:00BWDeciphera Pharmaceuticals Announces First Quarter 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock